Top 10 Industries Antiparasitic Drugs Market (2025–2035): Expert View by Spherical Insights
RELEASE DATE: Oct 2025 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Antiparasitic Drugs Market Size is projected to Grow from USD 23.86 Billion in 2024 to USD 44.15 Billion by 2035, at a CAGR of 5.75% during the forecast period 2025–2035. Rising parasitic infection rates, increased international travel and migration, and an increase in public awareness campaigns and educational initiatives are some of the factors contributing to the market's rapid growth. The market for antiparasitic medications is expanding due to the environment, poor water quality, insect bites, and the rising incidence of parasite infections like malaria, toxoplasmosis, etc.
Introduction
Antiparasitic drugs are a particular class of medication used to treat a variety of parasitic diseases, including those brought on by helminths, parasitic fungi, ectoparasites, protozoa, amoeba, and many more. Antiparasitic medications can kill the parasite, stop it from growing and reproducing, or stop it from infecting the host, among other ways. Furthermore, parasitic diseases are spreading throughout the world as a result of increased migration and international travel. There is a risk of local transmission when migrants and travellers bring parasitic infections from endemic to non-endemic areas. In areas where these illnesses were not previously prevalent, this mobility has increased the demand for antiparasitic medications. In these new areas, controlling public health risks and containing outbreaks depend on the prevention and treatment of parasitic infections. The pharmaceutical industry, academic institutions, and governmental organisations are also making large investments in research and development (R&D), which has influenced the market expansion.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights-Download the Brochure now and dive deeper into the future of the Antiparasitic Drugs Market.
Antiparasitic Drugs Market Size & Statistics
- The Market Size for Antiparasitic Drugs Was Estimated to be worth USD 23.86 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 5.75% between 2025 and 2035.
- The Global Antiparasitic Drugs Market Size is anticipated to reach USD 44.15 Billion by 2035.
- Asia Pacific is expected to grow at the highest share during the forecast period in the antiparasitic drugs market.
- North America is projected to grow at the fastest CAGR during the forecast period in the antiparasitic drugs market.
Regional growth and demand
North America is estimated to grow the fastest during the forecast period in the antiparasitic drugs market. The market is expanding as a result of consumers' increased health consciousness and the expansion of the healthcare system. The market for antiparasitic medications is expanding more quickly due to rising investments in the construction of healthcare facilities and the reputable pharmaceutical sector. The increasing R&D and the launch of innovative videos are driving the demand for the market.
Asia Pacific is anticipated to generate the highest demand during the forecast period in the antiparasitic drugs market. The market for antiparasitic medications is anticipated to grow significantly in the Asia Pacific due to the pharmaceutical industries and the expanding healthcare infrastructure in countries like China, India, and Japan are responsible for the market's expansion. The pharmaceutical industry's continuous technological advancements and the introduction of novel medications are contributing to the expansion of the antiparasitic medication market in the region.
Top 10 Trends in the Antiparasitic Drugs Market
- Rising Global Burden of Parasitic Diseases
- Innovation in Drug Formulations
- Resistance to Existing Therapies
- Expansion of Global Health Initiatives
- Growth in Anthelmintic and Antiprotozoal Segments
- Shift Toward Community and Home-Based Care
- Regional Market Expansion
- Genomic and Biomarker-Based Drug Development
- Digital Health and Surveillance Integration
- Strategic Collaborations and Licensing
1. Rising Global Burden of Parasitic Diseases
The need for antiparasitic treatments is being driven by the rising incidence of helminth infections, leishmaniasis, and malaria in developing nations.
2. Innovation in Drug Formulations
Particularly in rural areas, new delivery methods (such as long-acting injectables and nanoformulations) are increasing patient compliance and efficacy.
3. Resistance to Existing Therapies
Research into new compounds and combination therapies is being prompted by drug resistance in parasites such as Giardia and Plasmodium.
4. Expansion of Global Health Initiatives
Mass drug administration (MDA) programs are being expanded by WHO and NGOs, particularly for neglected tropical diseases (NTDs), which is increasing market volume.
5. Growth in Anthelmintic and Antiprotozoal Segments
The growing diversity across drug classes, anthelmintics (such as benzimidazoles) and antiprotozoals (such as metronidazole) continues to be the most common.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the antiparasitic drugs market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 10 Companies Leading the Antiparasitic Drugs Market
- Bayer AG
- Cipla Inc.
- Dr Reddy’s Laboratories Ltd
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Ltd
- Ipca Laboratories Ltd.
- Mankind Pharma
- Novartis AG
- Sanofi
- Zydus Group
1. Bayer AG
Headquarters: Leverkusen, Germany
A prominent player in the market for antiparasitic medications, Bayer AG is regarded as a top pharmaceutical and life sciences corporation worldwide. The company targets diseases brought on by helminths, ectoparasites, and protozoa by developing, producing, and distributing a range of antiparasitic treatments for human and animal health. Drugs for gastrointestinal nematodes, malaria, and other parasitic infections are part of Bayer's portfolio, which helps manage endemic and newly emerging parasitic diseases globally.
2. Cipla Inc.
Headquarters: Maharashtra, India
The company focuses on creating antiparasitic drugs that are accessible and reasonably priced, meeting the needs of both human and veterinary healthcare. Oral and injectable formulations for intestinal worms, malaria, and other parasitic infestations common in developing nations are part of Cipla's extensive product line. The market for antiparasitic drugs is expected to grow significantly as a result of increased public health initiatives and the rising prevalence of parasitic infections. Cipla is dedicated to fighting parasitic diseases, especially in areas with a high disease burden, and has a strong research and development capability in addition to an expanding global footprint.
3. Dr Reddy’s Laboratories Ltd
Headquarters: Telangana, India
The company treats both human and animal health by providing a wide variety of antiparasitic drugs that target infections brought on by helminths, ectoparasites, and protozoa. Dr Reddy's, which is well-known for its dedication to providing affordable healthcare, creates both branded and generic antiparasitic medications to help fight the common parasitic diseases in developing nations. With a global presence and robust research and development capabilities, Dr Reddy's is essential in increasing access to potent antiparasitic medications and meeting the rising demand brought on by an increase in parasitic infections globally.
4. GlaxoSmithKline plc
Headquarters: Brentford, London
The company specialises in the development and manufacturing of antiparasitic drugs, including albendazole and other combination treatments, which are commonly used to treat parasitic infections like schistosomiasis, intestinal worms, and lymphatic filariasis. By collaborating with international organisations such as the WHO, GSK provides billions of doses of antiparasitic medications to endemic areas as part of its active participation in global health initiatives. Their ongoing investments in production facilities in nations like South Africa and India are intended to increase production capacity in order to satisfy the rising demand for potent antiparasitic treatments worldwide, especially in environments with limited resources.
5. Ipca Laboratories Ltd.
Headquarters: Mumbai, India
A major participant in the market for antiparasitic medications, Ipca Laboratories Ltd. provides a broad range of pharmaceutical products, including important antiparasitic formulations. Their product line includes generic medications for treating parasitic infections, including albendazole (marketed as Nemozole) and other anti-infectives. To satisfy demand both domestically and abroad, the company concentrates on producing high-quality, reasonably priced drugs that treat infectious and parasitic diseases. With a significant global footprint and a focus on quality in research and manufacturing, Ipca caters to both developed and emerging markets, making a significant contribution to the antiparasitic therapeutic market.
Are you ready to discover more about the Antiparasitic Drugs market?
The report provides an in-depth analysis of the leading companies operating in the global antiparasitic drugs market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Bayer AG
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Cipla Inc.
- Dr Reddy’s Laboratories Ltd
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Ltd
- Ipca Laboratories Ltd.
- Mankind Pharma
- Novartis AG
- Sanofi
- Zydus Group
- Others.
Conclusion
The Market Size for Antiparasitic Medications is expected to grow at a compound annual growth rate (CAGR) of 5.75%, from USD 23.86 billion in 2024 to USD 44.15 billion by 2035. The rising parasite infections, more international travel and migration, as well as improved public awareness and healthcare initiatives, are the main causes of this growth. North America is predicted to grow at the fastest rate due to rising health consciousness and healthcare investments, while the Asia Pacific is expected to hold the largest market share due to growing healthcare infrastructure and pharmaceutical advancements.
Browse Related Reports
Global Switchgear Market Size To Exceed USD 9.22 Billion by 2035 | CAGR of 7.79% : Market Study Report
Global Fluoropolymer Films Market Size To Exceed USD 4.24 Billion by 2035 | CAGR of 12.07% : Industry Report
Global Isaac Mertens Syndrome Market Size To Exceed USD 573.31 Million by 2035 CAGR 4.72%: Market Study Report
Global Maple Syrup Urine Disease Treatment Market Size Exceed To USD 11.05 Billion in 2024|CAGR of 11.08%: Industry Report
Global Reduced Fat Butter Market Size To Exceed 1.71 Billion by 2035 | CAGR of 4.18%: Forecast Analysis Report
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?